Typical Versus Atypical Antipsychotics for Acute Mania

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Neuroscience

Background:

• Mania presents significant treatment challenges.
• Typical antipsychotics show efficacy but are associated with adverse effects.
• Atypical antipsychotics offer an alternative with a potentially better side effect profile.

Purpose of the Study:

• To examine the progression of acute manic episodes.
• To assess the relationship between manic symptom severity changes and antipsychotic treatment type.
• To compare the effectiveness of typical versus atypical antipsychotics in managing mania.

Main Methods:

• A case record study of patients admitted with mania (ICD-10 codes F30, F31.0-F31.2, F31.6).
• Standardized doses of antipsychotics (typical and atypical) were used, defined by WHO guidelines.
• Mania severity was assessed using the Modified Bech-Rafaelsen Mania Scale (MAS-M), administered by nurses up to three times daily.
• Linear regression within a mixed-model approach was employed to compare MAS-M scores over time between treatment groups.

Main Results:

• The study included 56 admissions from 46 patients.
• Manic episode severity (MAS-M) showed significant inter-patient variability.
• Patients on typical antipsychotics had higher baseline MAS-M scores, more recent admissions, and higher rates of mechanical restraint.
• After adjustment for covariates, the difference in mania reduction between atypical and typical antipsychotics was not statistically or clinically significant (-0.02 MAS-M points/day).

Conclusions:

• The rate of improvement in mania was comparable between patients treated with typical and atypical antipsychotics.
• These findings support the recommendation of atypical antipsychotics over typical ones for managing acute mania due to a lower risk of severe side effects.
• Atypical antipsychotics represent a viable and potentially safer option for acute manic episode management.